Eosinophil degranulation is more important than Eosinophilia in identifying asthma in chronic cough

Journal of Asthma

Volumn 48, Issue 10, 2011, Pages 994-1000

  Kim, Chang Keun ^a   Callaway, Zak ^a,b   Kim, Dong Won ^a   Kita, Hirohito ^c  

^a Inje University College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c MAYO CLINIC   (United States)

Author keywords

Eosinophil; Eosinophil derived neurotoxin; Major basic protein; Markers; Sputum

Indexed keywords

MAJOR BASIC PROTEIN; MYELOPEROXIDASE; NEUROTOXIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL DEGRANULATION; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; RADIOIMMUNOASSAY; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHIAL PROVOCATION TESTS; CELL COUNT; CELL DEGRANULATION; CHEMOKINE CCL24; CHRONIC DISEASE; COUGH; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILIA; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; SPUTUM; YOUNG ADULT;

EID: 82255176851     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.623335     Document Type: Article

References (40)

1. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323(15): 1033-1039. (Pubitemid 20336962)
2. Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992; 145(6): 1469-1476.
3. Wardlaw AJ, Brightling C, Green R,Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000; 56(4): 985-1003. (Pubitemid 32417164)
4. Leckie M, Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356(9248):2144-2148.
5. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit CareMed 2003; 167(2):199-204. (Pubitemid 36076080)
6. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360(10):973-984.
7. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360(10):985-993.
8. Moqbel R, Lace P, Adamko DJ, Odemuyiwa SO. Allergy: Principles & Practice. Chapter 18, Biology of Eosinophils. St. Louis, MO: Mosby, 2008:295-310.
9. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999; 29(9):1172-1186. (Pubitemid 29406464)
10. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE. Indices of airway nflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154(2 Pt 1):308-317. (Pubitemid 26269096)
11. Boulet LP, Milot J, Boutet M, St Georges F, Laviolette M. Airway inflammation in nonasthmatic subjects with chronic cough. Am J Respir Crit Care Med 1994; 149(2 Pt 1):482-489. (Pubitemid 24069000)
12. Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley MJ. A systematic evaluation of mechanisms in chronic cough. Am J Respir Crit Care Med 1997; 156(1):211-216. (Pubitemid 27293191)
13. Irwin RS, Rosen MJ, Braman SS. Cough: a comprehensive review. Arch Intern Med 1977; 137:1186-1191.
14. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147(5):1126-1131. (Pubitemid 23149867)
15. Belda J, Leigh R, Parameswaran K, O'Byrne PM, SearsMR, Hargreave FE. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161(2 Pt 1):475-478. (Pubitemid 30129455)
16. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1(8651):1346-1348. (Pubitemid 19151953)
17. Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy 1995; 25(2):127-132.
18. McGarvey LP, Forsythe P, Heaney LG, MacMahon J, Ennis M. Bronchoalveolar lavage findings in patients with chronic nonproductive cough. Eur Respir J 1999; 13(1):59-65. (Pubitemid 29079220)
19. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92(4):537-548. (Pubitemid 23317079)
20. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose corticosteroids. Am J Respir Crit Care Med 1997; 156(3 Pt 1):737-743. (Pubitemid 27396409)
21. Cai Y, Carty K, Henry RL, Gibson PG. Persistence of sputum eosinophilia in children with controlled asthma compared with healthy children. Eur Respir J 1998; 11(4):848-853. (Pubitemid 28231277)
22. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160(3):1001-1008. (Pubitemid 29442043)
23. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52(6):498-501. (Pubitemid 27298498)
24. Turner MO, Hussack P, Sears MR, Dolovich J, Hargreave FE. Exacerbations of asthma without sputum eosinophilia. Thorax 1995; 50(10):1057-1061.
25. Pavord ID, Brightling CE,Woltmann G,Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353(9171): 2213-2214. (Pubitemid 29295261)
26. Monteseirin J, Bonilla I, Camacho J, Conde J, Sobrino F. Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol 2001; 107(4):623-626. (Pubitemid 32397748)
27. Niimi A, Torrego A, Nicholson AG, Cosio BG, Oates TB, Chung KF. Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol 2005; 116(3):565-570. (Pubitemid 41267129)
28. Gleich GJ, Adolphson CR. Interleukin-5: From Molecule to Drug Target for Asthma, (Lung Biology in Health and Disease). Chapter 1, The Eosinophil and Bronchial Asthma: Evidence for a Critical Role of Eosinophils in Pathophysiology. New York: Marcel Dekker, Inc., 1999:1-37.
29. Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol 1995; 154(9):4749-4758.
30. Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991; 87(4):1470-1473.
31. Kikuchi I, Kikuchi S, Kobayashi T, Hagiwara K, Sakamoto Y, Kanazawa M, Nagata M. Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils. Am J Respir Cell Mol Biol 2006; 34(6):760-765. (Pubitemid 43825342)
32. Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 2004; 114(3):568-574. (Pubitemid 39194930)
33. Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2001; 26(1):79-82. (Pubitemid 32372658)
34. Kim CK, Callaway Z, Fletcher R, Koh YY. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. J Asthma 2010; 47(5):568-573.
35. Park SW, Kim DJ, Chang HS, Park SJ, Lee YM, Park JS, Chung IY, Lee JH, Park CS. Association of interleukin-5 and eotaxin with acute exacerbation of asthma. Int Arch Allergy Immunol 2003; 131(4): 283-290. (Pubitemid 36980761)
36. Oh JW, Lee HB, Kim CR, Yum MK, Koh YJ, Moon SJ, Kang JO, Park IK. Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma. Ann Allergy Asthma Immunol 1999; 82:491-496.
37. Scheicher ME, Teixeira MM, Cunha FQ, Teixeira AL Jr., Filho JT, Vianna EO. Eotaxin-2 in sputum cell culture to evaluate asthma inflammation. Eur Respir J 2007; 29(3):489-495. (Pubitemid 46372095)
38. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 2000; 106(3):507-513. (Pubitemid 32037703)
39. Jinquan T, Quan S, Feili G, Larsen CG, Thestrup-Pedersen K. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol 1999; 162(7): 4285-4292. (Pubitemid 29314820)
40. Jahnz-Rozyk K, Plusa T, Mierzejewska J. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function. Mediators Inflamm 2000; 9(3-4):175-179.